Evercore ISI made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1. The firm added Align Technology (ALGN) to its “Tactical Outperform” list and keeps an Outperform rating and $200 price target on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Early notable gainers among liquid option names on March 19th
- Morning Movers: Canadian Solar sinks following fourth quarter results
- Elliott builds stake in Align, to seek ways to lift stock price, Bloomberg says
- Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
- DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls